Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
9.84
-0.27 (-2.67%)
At close: Aug 28, 2026, 4:00 PM EDT
9.83
-0.02 (-0.15%)
After-hours: Aug 28, 2026, 4:10 PM EDT

Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $293.11 million. The enterprise value is $288.95 million.

Market Cap293.11M
Enterprise Value 288.95M

Important Dates

The last earnings date was Wednesday, August 12, 2026, after market close.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

TTRX has 29.79 million shares outstanding. The number of shares has increased by 7.08% in one year.

Current Share Class 29.79M
Shares Outstanding 29.79M
Shares Change (YoY) +7.08%
Shares Change (QoQ) +1.06%
Owned by Insiders (%) 58.79%
Owned by Institutions (%) 3.94%
Float 10.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 426.73
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 8.91.

Current Ratio 1.19
Quick Ratio 1.17
Debt / Equity 8.91
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -38.36

Financial Efficiency

Return on equity (ROE) is -686.28% and return on invested capital (ROIC) is -123.26%.

Return on Equity (ROE) -686.28%
Return on Assets (ROA) -50.27%
Return on Invested Capital (ROIC) -123.26%
Return on Capital Employed (ROCE) -104.47%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$4.22M
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 8.80
200-Day Moving Average 5.17
Relative Strength Index (RSI) 54.98
Average Volume (20 Days) 51,261

Short Selling Information

The latest short interest is 114,828, so 0.39% of the outstanding shares have been sold short.

Short Interest 114,828
Short Previous Month 84,329
Short % of Shares Out 0.39%
Short % of Float 1.06%
Short Ratio (days to cover) 1.47

Income Statement

Revenue n/a
Gross Profit -1.61M
Operating Income -8.56M
Pretax Income -8.45M
Net Income -8.45M
EBITDA -8.51M
EBIT -8.56M
Earnings Per Share (EPS) -$0.29
Full Income Statement

Balance Sheet

The company has $10.29 million in cash and $6.12 million in debt, with a net cash position of $4.17 million or $0.14 per share.

Cash & Cash Equivalents 10.29M
Total Debt 6.12M
Net Cash 4.17M
Net Cash Per Share $0.14
Equity (Book Value) 686,888
Book Value Per Share 0.02
Working Capital 1.66M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.32M
Capital Expenditures n/a
Depreciation & Amortization 56,816
Net Borrowing 6.72M
Free Cash Flow -4.32M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.07%
Shareholder Yield -7.07%
Earnings Yield -2.88%
FCF Yield -1.47%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1